CA-VISA
2.2.2021 13:02:12 CET | Business Wire | Press release
Visa Inc. (NYSE: V) today announced VisaNet +AI, a suite of AI-powered services that address long-standing challenges and pain points for banks, merchants and consumers—including delays and confusion with managing account balances and the unpredictability of daily settlement for financial institutions. VisaNet +AI comprises several innovative concepts and new value-added services, including Visa Smarter Posting and Visa Smarter Settlement Forecast, as well as Visa Smarter Stand-In Processing (Smarter STIP), a capability announced in August of last year. These innovations harness Visa’s high-performance AI platform to help make payments more predictable, transparent, and speedy.
“Our clients, partners and cardholders look to us for actionable data-driven insights to better manage their businesses and financial lives, especially during these unprecedented times. Today we’re announcing a set of services that use AI to make it easier for consumers to manage their accounts, and for financial institutions to manage their business,” said Jack Forestell, executive vice president and chief product officer, Visa. “With our investment in AI infrastructure, we’re unlocking novel, real-time solutions to complex problems. This is just the beginning of what we can do with the predictive power of AI.”
Smarter Posting helps provide greater transparency for consumers
Today’s digital-native consumers expect real-time visibility into their finances as they increasingly conduct banking on mobile and online platforms. However, the payment experience for consumers can be inconsistent, with some purchases taking longer to finalize on their balance than others. This lag can create confusion or concern for cardholders, resulting in increased call center volume or potential overdrafts.
This delay occurs because the amount authorized in real-time at the checkout counter can differ from the amount eventually cleared from a consumer’s account. For example, the final amount can change when a restaurant-goer adds a tip at a restaurant, or when a cross-border payment happens involving multiple currencies. To prevent consumer confusion from seeing multiple charges for a single transaction, banks often delay posting the payment or updating the account balance until they have certainty about the final amount.
To help issuers create a better banking experience for cardholders, Visa developed Smarter Posting, a service that uses AI to deliver a customized score for each transaction as part of the authorization process. The Smarter Posting model analyzes transaction details and historical data to predict the likelihood that a transaction amount will remain consistent through clearing. In testing, the model has achieved 98% accuracy1 in predicting whether the transaction amount will likely remain stable, giving financial institutions added intelligence to provide a more consistent end-to-end payment experience, for example, by provisionally updating the account balance that a cardholder sees.
Visa Smarter Posting will be initially available in Europe in April 2021 and is slated to expand globally in the near future.
Smarter Settlement Forecast uses predictive modeling to anticipate cash flow needs
Every day during the settlement process, Visa enables the movement of billions of dollars across thousands of institutions in more than 200 countries and territories and 160 currencies. It’s the final step in the payment cycle, where transactions are aggregated, transfers are facilitated between acquirers and issuers, and merchant accounts are credited for the sales they’ve made.
This process requires financial institutions to strategically allocate resources—so that there is enough liquidity to meet the day’s settlement volume, without over-allocating resources that could be leveraged elsewhere in their business. Today’s volatile environment has underscored the challenge treasury teams face in predicting daily volumes and making strategic decisions.
Visa created Smarter Settlement Forecast to provide clients with customized 7-day forecasts of the settlement amount they may need on hand each day. The service uses information generated by historical settlement volumes, seasonal indicators, macro-trends, outlier events, such as those surrounding COVID-19, and real-time transaction data to provide high quality predictions of cash outflows and inflows. These forecasts can help issuers and acquirers optimize treasury and liquidity management processes, and assist financial institutions settling in multiple currencies with predictions for each currency.
Smarter Settlement Forecast is slated to be made available to eligible clients through a subscription in the Visa Analytics Platform, thereby simplifying integration for clients. Visa is currently piloting the service with three clients ahead of its formal launch planned for later this year.
Smarter STIP can improve payment experiences during outages
Visa Smarter Stand-In Processing (Smarter STIP), the first of the VisaNet +AI capabilities announced in August 2020, has gained traction among leading financial institutions globally. Smarter STIP uses deep learning to help financial institutions increase transaction authorizations during outages. Smarter STIP generates an informed decision to approve or decline transactions on behalf of issuers to provide consumers with a frictionless Visa payment experience.
Since its release, Smarter STIP has seen strong issuer interest across every Visa region. In just two months, clients around the world have added Smarter STIP to their suite of Visa solutions, including Caixa Econômica Federal, and Doha Bank.
“In Visa we have a partner that is driving new innovations in AI for payments,” said Mr. Braik Ali H S Al – Marri, Chief Retail Banking Officer, Doha Bank, Qatar. “With VisaNet +AI we can harness those innovations and drive new value for our business and customers.”
About Visa Inc.
Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device for everyone, everywhere. As the world moves from analog to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa , visa.com/blog and @VisaNews .
1 Visa data based on analysis comparing the model prediction of when authorization and clearing amounts will remain consistent. Analysis conducted on historical transaction data (August - September 2020) for 150 million transactions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210202005166/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
